Mr. Craig Loverock reports
CONTAGIOUS GAMING UPDATE ON TRANSACTION WITH IMBIOTECHNOLOGIES
Contagious Gaming Inc. has provided an update regarding the previously announced proposed
combination with IMBiotechnologies Ltd.
As previously announced on July 17, 2024, the company entered into a non-binding letter of intent with
IMBiotechnologies, pursuant to which the parties intend to complete a transaction that would constitute
a reverse takeover of the company.
The company and IMBiotechnologies continue to advance the transaction and remain engaged in
negotiations toward the execution of a definitive agreement. The parties are also continuing their
respective due diligence investigations and working with advisers to determine the optimal legal
structure for the transaction.
In parallel with the transaction, IMBiotechnologies continues to evaluate and advance plans for a
concurrent financing, the proceeds of which are expected to be used to support commercialization
activities and general corporate purposes.
The completion of the transaction remains subject to a number of conditions, including, but not limited
to:
-
Negotiation and execution of a definitive agreement;
-
Completion of satisfactory due diligence by both parties;
-
Completion of any required financing;
-
Receipt of all required shareholder and regulatory approvals;
-
Satisfaction of other customary closing conditions.
There can be no assurance that the transaction will be completed as proposed or at all.
Trading in the company's common shares remains halted in accordance with the policies of the TSX
Venture Exchange and is expected to remain halted until such time as the exchange determines that
trading may resume.
The company will provide further updates as material developments occur.
About Contagious Gaming
Inc.
Contagious Gaming is in the business of developing and investing in software solutions for
regulated gaming and lottery markets. The company is focused on leveraging its existing assets for the
B2B (business-to-business) gaming marketplace.
We seek Safe Harbor.
© 2026 Canjex Publishing Ltd. All rights reserved.